Novak Djokovic is turning back the clock down under and will now go for a record after an incredible performance at the 2026 Australian Open. Djokovic pulled off a massive upset over No. 2 seed and ...
RELATIVITY-123: A phase 3, randomized, open-label study of nivolumab (NIVO) + relatlimab (RELA) fixed-dose combination (FDC) versus regorafenib or trifluridine + tipiracil (TAS-102) in later-line ...
Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...
A phase 1/2 study with open-label, dose escalation phase followed by single-arm expansion at the maximum tolerated dose to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results